Nursing care
Kawasaki Disease nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Kawasaki disease nursing care starts with recognising fever lasting five days or more alongside strawberry tongue, conjunctival injection, rash, and peeling hands or feet. The urgency is not the rash itself but the risk of coronary artery aneurysm, which is why early IVIG and aspirin therapy and cardiac monitoring drive every nursing decision.
Recognising it at the bedside
Kawasaki disease presents as a fever of five days or longer that does not respond to standard antipyretics, occurring alongside at least four of five classic features: bilateral non-exudative conjunctival injection, oral changes including a strawberry tongue and cracked red lips, a polymorphous rash, extremity changes such as swelling or redness of the hands and feet, and cervical lymphadenopathy, usually a single enlarged node.
The child is typically under five years old and often strikingly irritable, more so than the fever alone would explain. Peeling of the fingertips and toes tends to appear later, in the subacute phase around week two, so a nurse assessing a child on day five may see the fever and rash but not yet the desquamation. Waiting for peeling to confirm the diagnosis delays treatment and increases coronary risk.
Why the classic presentation misleads
The five features read like a straightforward checklist, but Kawasaki disease is a vasculitis, and the visible signs are the least dangerous part of it. The real threat is coronary artery inflammation that can progress to aneurysm formation, and that process is already underway during the febrile phase, well before hands start peeling. A nurse who treats the presentation as 'just a rash and fever' is missing the reason the disease is treated as a cardiac emergency.
Incomplete Kawasaki disease, where a child has persistent fever with fewer than four classic features, is common in infants under twelve months and is easy to miss. These infants are at higher risk of coronary complications precisely because the atypical picture delays diagnosis. Any infant with unexplained fever lasting five or more days deserves Kawasaki disease on the differential, even without the full symptom set.
Priority nursing actions
Once Kawasaki disease is suspected, the priority is rapid identification and escalation to enable IVIG administration within the first ten days of illness, since earlier treatment substantially lowers the risk of coronary aneurysm. Establish IV access, obtain baseline vital signs including a careful assessment for tachycardia and any murmur, and prepare for echocardiography.
Provide comfort measures for the irritable, feverish child: dim lighting for conjunctival injection, mouth care for cracked lips, and gentle skin care for the rash and later desquamation. Monitor fluid balance closely during IVIG infusion, since these children are often volume-depleted from days of fever and poor intake, and IVIG itself is a large volume load that stresses an already inflamed cardiovascular system.
Labs and diagnostics to expect
Expect markedly elevated inflammatory markers, ESR and CRP, along with leukocytosis and a rising platelet count that becomes especially pronounced in the second to third week of illness, a pattern distinct from most other paediatric febrile illnesses. Mild anaemia and elevated liver enzymes are also common.
Echocardiography is the key diagnostic and monitoring tool, performed at diagnosis and repeated at intervals, commonly around two and six to eight weeks after onset, to track coronary artery diameter. Nurses should know that a normal initial echocardiogram does not rule out later aneurysm formation, which is why the follow-up schedule matters as much as the first scan.
Complications and their early signs
Coronary artery aneurysm is the complication that defines long-term risk, and it can be asymptomatic until it causes thrombosis, myocardial ischaemia, or, rarely, rupture. Watch for chest pain, unexplained irritability in an infant who cannot verbalise pain, pallor, and signs of poor perfusion, all of which can signal myocardial involvement.
Myocarditis and pericardial effusion can occur in the acute phase, so monitor for tachycardia disproportionate to fever, gallop rhythm, or muffled heart sounds. Macrophage activation syndrome is a rarer but serious complication, presenting with persistent fever, worsening cytopenias, and rising ferritin despite treatment, and it needs urgent recognition.
Teaching that changes outcomes
Teach families that aspirin therapy continues after discharge, at a lower dose once fever resolves, and that it must be paused during active varicella or influenza infection because of the risk of Reye syndrome, with the prescriber notified for guidance on an alternative during that window. Reinforce the importance of attending every follow-up echocardiogram, even once the child looks completely well, since coronary changes can be silent.
Explain that live vaccines, particularly MMR and varicella, need to be deferred for about eleven months after IVIG because the antibodies in IVIG can blunt the vaccine response. Give families clear return precautions: chest pain, fainting, or unusual fatigue in a child with known coronary involvement warrants immediate medical review, not a routine appointment.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pediatrics practice questions are the closest set to what this page covers.
Common questions
How is Kawasaki disease diagnosed if there is no single confirmatory test?
Diagnosis is clinical, based on fever for five or more days plus at least four of the five classic features, supported by inflammatory markers and echocardiography. Incomplete presentations are diagnosed using supplemental laboratory criteria, especially in infants under twelve months.
Why is aspirin used in a child when it is usually avoided because of Reye syndrome risk?
Aspirin's anti-inflammatory and antiplatelet effects are used deliberately in Kawasaki disease to reduce coronary thrombosis risk, outweighing the Reye syndrome concern in this specific context. Therapy is paused during active varicella or influenza infection, when that risk rises.
What happens if IVIG is given after the tenth day of illness?
IVIG is still given if Kawasaki disease is diagnosed later, since ongoing inflammation still benefits from treatment, but coronary aneurysm risk rises the longer treatment is delayed. This is why early recognition, even with an incomplete symptom picture, matters so much.
Can a child with Kawasaki disease have a normal heart and still develop problems later?
Yes. A normal initial echocardiogram does not guarantee the coronaries stay normal, which is why repeat imaging at around two and six to eight weeks is standard. Long-term cardiology follow-up continues for children who developed aneurysms.
Why do infants get missed more often with Kawasaki disease?
Infants under twelve months frequently present with incomplete Kawasaki disease, showing fewer than four classic features alongside prolonged fever, which delays suspicion. This group also carries a higher risk of coronary involvement, making a low threshold for testing especially important.